Okay, let's tackle this question. The user wants me to explain which drug acts on motilin receptors. First, I need to recall what motilin does. Motilin is a gastrointestinal hormone that stimulates gastrointestinal motility, especially during the interdigestive period. The receptors for motilin are known as motilin receptors.

Now, thinking about drugs that target these receptors. I remember that erythromycin is a macrolide antibiotic that also acts as a motilin receptor agonist. It's used in the treatment of gastroparesis because it enhances gastric emptying by stimulating motilin receptors. So the correct answer should be erythromycin.

Looking at the options, if one of them is erythromycin, that's the right choice. The other options might include drugs like metoclopramide, which is a dopamine antagonist and 5-HT4 agonist, not motilin. Domperidone is another dopamine antagonist. Cisapride is a 5-HT4 agonist. So those don't act on motilin receptors.

The core concept here is understanding the pharmacological actions of drugs on different receptors in the gastrointestinal tract. The clinical pearl is remembering that erythromycin's motilin agonism is a key point in its use beyond antibiotic therapy.

**Core Concept**
Motilin receptors are G-protein-coupled receptors in the gastrointestinal tract that regulate peristalsis and gastric emptying. Activation of these receptors enhances intestinal motility via the motilin receptor-mediated signaling pathway.

**Why the Correct Answer is Right**
**Erythromycin** is a macrolide antibiotic that also acts as a motilin receptor agonist. It binds to motilin receptors in the stomach and small intestine, triggering the release of acetylcholine and increasing peristaltic contractions. This effect is utilized clinically in treating gastroparesis. Unlike true motilin, erythromycin's activity is non-endogenous but pharmacologically relevant.

**Why Each Wrong Option is Incorrect**
**Option A:** *Metoclopramide* is a dopamine D2 receptor antagonist and 5-HT4 agonist; it does not interact with motilin receptors.
**Option B:** *Domperidone* is a dopamine D2 receptor antagonist; its prokinetic effects are unrelated to motilin.
**Option C:** *Cisapride* is a 5-HT4 receptor agonist, enhancing intestinal motility via a different mechanism.

**Clinical Pearl / High-Yield Fact**
Erythromycin’s motilin agonism is a key off-label use in managing delayed gastric emptying. However, prolonged use can lead to antibiotic resistance and is contraindicated in patients with cardiac arrhythmias due to QT prolongation risk.

**Correct Answer: C. Erythromycin**

✓ Correct Answer: A. Erythromycin